Evaluation and Detection Osteoporosis among Rheumatoid Arthritis Patients by Dual -enegy x-ray Absorpotiometry (Dexa)

The Dual-energy X-ray Absorptiometry (DXA) is a pivotal diagnostic tool for detecting osteoporosis and monitoring treatment response, due to its speed and wide availability, measurement accuracy, and low radiation exposure. Early detection of osteoporosis in patients can reduce the incidence of fractures, worsening of the disease, and high economic burdens on individuals and health systems. This research aims to highlight the vital role of DXA in the detection of osteoporosis in rheumatoid patients, and to explore the main causes that have a significant role in the progression of the osteoporosis stage. This study included a group of rheumatic patients with osteoporosis, of both sexes, approximately between the ages of 30 and 80 years. The total number of samples reached 40 patients, where part of the images were obtained from patients who were photographed during their visit to the clinics (Al-Diqqa Clinic, Clinic Al-Masarra, The Advance center for medical imaging ), while the rest of the data were collected from the patients who had pictures and results of tests ready. Through the research, we found that females are more likely to develop osteoporosis than males, because the percentage of mineral density in women is lower than in males in all locations, in addition to the increase in the incidence rate with age. We also noted an association between low vitamin D levels and an increased risk of osteoporosis (P<0.01), as the level of vitamin D in patients with osteoporosis decreases with age. Conclusions: DEXA plays an important role in evaluating osteoarthritis, especially in patients with rheumatoid arthritis. It is the gold standard for diagnosing osteoarthritis and improving the chances of predicting fracture risks and evaluating treatment by providing information about bone density, quality and strength.